These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12788925)

  • 1. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation.
    Georgel PT; Horowitz-Scherer RA; Adkins N; Woodcock CL; Wade PA; Hansen JC
    J Biol Chem; 2003 Aug; 278(34):32181-8. PubMed ID: 12788925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
    Nan X; Campoy FJ; Bird A
    Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.
    Fuks F; Hurd PJ; Wolf D; Nan X; Bird AP; Kouzarides T
    J Biol Chem; 2003 Feb; 278(6):4035-40. PubMed ID: 12427740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.
    Hansen JC; Ghosh RP; Woodcock CL
    IUBMB Life; 2010 Oct; 62(10):732-8. PubMed ID: 21031501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal regulation by MeCP2: structural and enzymatic considerations.
    Bowen NJ; Palmer MB; Wade PA
    Cell Mol Life Sci; 2004 Sep; 61(17):2163-7. PubMed ID: 15338046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
    Jones PL; Veenstra GJ; Wade PA; Vermaak D; Kass SU; Landsberger N; Strouboulis J; Wolffe AP
    Nat Genet; 1998 Jun; 19(2):187-91. PubMed ID: 9620779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.
    Majumder S; Kutay H; Datta J; Summers D; Jacob ST; Ghoshal K
    J Cell Biochem; 2006 Apr; 97(6):1300-16. PubMed ID: 16329111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA.
    Chandler SP; Guschin D; Landsberger N; Wolffe AP
    Biochemistry; 1999 Jun; 38(22):7008-18. PubMed ID: 10353812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Lorincz MC; Schübeler D; Groudine M
    Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.
    Kimura H; Shiota K
    J Biol Chem; 2003 Feb; 278(7):4806-12. PubMed ID: 12473678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rett syndrome: a surprising result of mutation in MECP2.
    Dragich J; Houwink-Manville I; Schanen C
    Hum Mol Genet; 2000 Oct; 9(16):2365-75. PubMed ID: 11005791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.
    Nikitina T; Shi X; Ghosh RP; Horowitz-Scherer RA; Hansen JC; Woodcock CL
    Mol Cell Biol; 2007 Feb; 27(3):864-77. PubMed ID: 17101771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
    Drewell RA; Goddard CJ; Thomas JO; Surani MA
    Nucleic Acids Res; 2002 Mar; 30(5):1139-44. PubMed ID: 11861904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
    Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
    Nan X; Meehan RR; Bird A
    Nucleic Acids Res; 1993 Oct; 21(21):4886-92. PubMed ID: 8177735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The solution structure of the domain from MeCP2 that binds to methylated DNA.
    Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
    J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery.
    Kaludov NK; Wolffe AP
    Nucleic Acids Res; 2000 May; 28(9):1921-8. PubMed ID: 10756192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
    Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
    Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.